US FDA turns down full approval of Amgen lung cancer drug Lumakras Ruchika Sharma29 Dec 2023 4:30 PM ISTNew Delhi: The U.S. health regulator on Tuesday declined to grant traditional approval to Amgen's Lumakras for treating lung cancer patients with...
Glenmark Pharma bags USFDA nod for generic version of Otezla Tablets Ruchika Sharma18 Oct 2023 3:30 PM ISTMumbai: Glenmark Pharmaceuticals Ltd. has announced that the Company has received final approval from the United States Food & Drug Administration...
Amgen settles patent lawsuit over biosimilar of JnJ's Stelara Ruchika Sharma25 May 2023 2:50 PM ISTStelara is a biologic drug, meaning it is derived from living cells and cannot be exactly duplicated.
Patent infringement: Amgen sues Novartis to block generic osteoporosis, bone cancer drugs Ruchika Sharma3 May 2023 5:30 PM ISTAmgen said the proposed biosimilars infringe 21 patents covering Prolia and Xgeva.
Amgen wins patent appeal on psoriasis drug Otzela against Zydus Pharma (USA), Sandoz Ruchika Sharma22 April 2023 1:30 PM ISTThousand Oaks: Amgen has announced that the U.S. Court of Appeals for the Federal Circuit has affirmed the judgment of the U.S. District...
AstraZeneca Tezspire approved for self administration in US with new pre filled pen Ruchika Sharma3 Feb 2023 12:15 PM ISTThe Tezspire pre-filled pen enables patients and caregivers to self-administer the medicine at home or in clinic via a simple process.
After Sanofi drops out of Horizon bid, Amgen emerges as frontrunner Ruchika Sharma12 Dec 2022 1:30 PM ISTSanofi said on Sunday that it was no longer in discussions with Horizon and does not intend to make an offer for it.
Sanofi, JnJ, Amgen in talks to acquire Horizon Therapeutics Ruchika Sharma1 Dec 2022 4:33 PM ISTBengaluru: Horizon Therapeutics Plc said on Tuesday its board was engaged in highly preliminary discussions with three pharmaceutical giants for...
Patent infringement: Johnson and Johnson sues Amgen over plan to sell drug similar to Stelara Ruchika Sharma1 Dec 2022 1:15 PM ISTIf Amgen launches its drug, J&J said it would infringe J&J's patent on the drug's active ingredient and on its use for treating ulcerative colitis.
US Supreme Court rejects Bristol Myers cancer drug Yescarta patent fight with Gilead Sciences Ruchika Sharma8 Nov 2022 4:30 PM ISTA Gilead spokesperson said the company was pleased with the Supreme Court's decision, which has "effectively ended" the dispute.
Amgen to acquire ChemoCentryx for USD 4 billion in cash Ruchika Sharma7 Aug 2022 2:15 PM ISTThousand Oaks: Amgen and ChemoCentryx, Inc., a biopharmaceutical company focused on orally administered therapeutics to treat autoimmune...
'Golden time for India to emerge as innovator nation in biopharma sector' Ruchika Sharma23 Jun 2022 3:30 PM ISTWashington: Post COVID19, it's a golden time for India to emerge as an innovator nation in the biopharma sector, organiser of the annual India-US...
